概述
本数据库收载了欧盟EMA(European Medicines Agency)经过集中程序批准在欧盟上市的2200余条药品详细信息,公众摘要、说明书等相关文件。
同时提取了授权产品信息PDF文件中药品授权编号、规格、剂型、给药途径、包装等信息,帮助用户便捷获取药品基本信息。
数据结构及样例
{
"产品编号":"EMEA/H/C/006105",
"药品名称":"Rytelo"
"通用名":"imetelstat",
"公司":"Geron Netherlands B.V.",
"活性成分":"imetelstat",
"活性成分(中)":"艾泰司他",
"规格":"47 mg;188 mg",
"剂型":"Powder for concentrate for solution for infusion",
"剂型(中)":"注射剂",
"给药途径":"Intravenous use",
"给药途径(中文)":"注射",
"批准日期":"2025-03-07",
"拒绝申请日期":"",
"市场状态":"Authorised",
"撤回申请日期":"",
"撤回批准日期":"",
"上市许可撤销/到期/失效日期":"",
"意见状态":"",
"意见日期":"",
"ATC":"L01XX80",
"药物治疗分类":"Antineoplastic agents",
"治疗领域":"Anemia;Myelodysplastic Syndromes",
"适应症":"Treatment of transfusion-dependent anaemia in adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS) who have failed to respond or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA). "
"孤儿药":"yes",
"补充监测":"yes",
"仿制药":"no",
"生物类似药":"no",
"加速审评":"no",
"条件批准":"no",
"特殊情况批准":"no",
"先进疗法":"no",
"优先药物":"no",
"更新日期":"2025-03-11",
"药物概述下载":"文件链接",
"药品说明书":"文件链接",
"授权产品信息":"文件链接",
"官网":"https://mri.cts-mrp.eu/portal/details?productnumber=HU/H/0403/003",
}